KHAN Technology Transfer Fund II
Dortmundkhanu.de
Overview
KHAN Technology Transfer Fund II is an early-stage life sciences venture fund that focuses on creating value through cooperative drug development partnerships with academic innovators in Europe, targeting first-in-class therapies for markets with a high unmet medical need.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| iDEL Therapeutics | Mar 2026 | Seed | Co-investor |
| iDEL Therapeutics | Mar 2026 | Seed | Co-investor |
| Nemea Therapeutics, Inc. | Nov 2025 | Pre Seed | Co-investor |
| KyDo Therapeutics | Sep 2025 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
